Prevention of thromboembolism in patients witth chronic atrial fibrillation in primary health care;Prevención de la enfermedad tromboembólica en pacientes con fibrilación auricular crónica en atención primaria

Medicina Clinica

Volumn 122, Issue 2, 2004, Pages 53-56

  Acicoya, Diego Martín ^a,c   Pérez, Pelayo Pedrero ^b   Martínez García, José Antonio ^a   González Álvaro, Alberto ^a   Hernando López, Teresa ^a   Herreros Hernanz, Isabel ^a  

^a EAP Las Calesas   (Spain)

^b EAP Guadarrama   (Spain)

^c NONE   (Spain)

Author keywords

Anticoagulation; Atrial fibrillation; Primary care

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MITRAL VALVE DISEASE; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RISK FACTOR; THERAPEUTIC ERROR; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

EID: 1142311016     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(04)74139-1     Document Type: Article

References (22)

1. Hankey GJ. Non-valvular atrial fibrillation and stroke prevention. National Blood Pressure Advisory Committe of the National Heart Foundation. Med J Aust 2001;174:234-9.
2. a ed. Madrid: McGraw Hill-Interamericana, 1998; p. 2644-72.
3. Almendral J, Marín E, Medina O, Peinado R, Pérez L, Ruiz R, et al. Guías de práctica clínica de la Sociedad Española de Cardiologia en arritmias cardiacas. Rev Esp Cardiol 2001;54:307-67.
4. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175-8.
5. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
6. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
7. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991;84:527-39.
8. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-12.
9. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-62.
10. Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
11. Aloy A, Cuenca R, Rollán E, Casanova JM. Utilización de fármacos antitrombóticos en pacientes con fibrilación auricular crónica en un área sanitaria comarcal. Med Clin (Barc) 1999;112:454-6.
12. Fuentes T, Martín E, Salgado F, Sánchez A, Martos F, González JA. Valoración del tratamiento antitrombótico en pacientes con fibrilación auricular crónica no valvular. Aten Primaria 1998;22:172-5.
13. Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 1999;137:307-12.
14. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998;97:1231-3.
15. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart 1998;79:50-5.
16. Garcia A, Marín F, Arrarte V, Sogorb F. Infrautilización del tratamiento anticoagulante en pacientes con fibrilación auricular. Med Clin (Barc) 2002;119:638.
17. Bertomeu V, Morillas PJ, González JR, Alegria E, García JM, González I, et al. Empleo de fármacos antitrombóticos en pacientes hipertensos con fibrilación auricular crónica. Estudio CARDIOTENS 99. Med Clin (Barc) 2002;118:327-31.
18. Rodriguez D, Casajuana J, Botinas M. Anticoagulación y fibrilación auricular no reumática. Aten Primaria 1998;21:553-5.
19. SIGN. Atrial fibrillation: prophylaxis of systemic embolism. Edinburgh: Scottish Intercollegiate Guidelines Network, 1999; p. 18-22.
20. King DE, Dickerson LM, Sack JL. Acute management of atrial fibrillation: part II. Prevention of thromboembolic complications. Am Fam Physician 2002;66:261-4, 271-2.
21. Ceresne L, Upshur RE. Atrial fibrillation in a primary care practice: prevalence and management. BMC Fam Pract 2002;3:11.
22. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852-923.